Longitudinal Impacts of Gastric Bypass Surgery on Pharmacodynamics and Pharmacokinetics of Statins
ConclusionDiscontinuations of statin dosing post-RYGB require LDL monitoring and reducing the dose to half seems to have better results. Patients on statin treatment post-RYGB should be followed-up closely based on our pharmacokinetic findings, to ensure therapeutic effects of the treatment with minimal adverse effects.
Source: Obesity Surgery - Category: Surgery Source Type: research
More News: Atorvastatin Calcium | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Cholesterol | Crestor | Eating Disorders & Weight Management | Gastric Bypass | Gastroenterology | Heart | Lipitor | Obesity | Rosuvastatin | Simvastatin | Statin Therapy | Study | Surgery | Weight Loss | Zivast | Zocor